- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
With the NFL preseason already underway, cannabis activists are shining a spotlight on the professional sports league to soften their stance on medical cannabis use among players. Roger Goodell, the league commissioner, has stated that he'd consider allowing athletes to use medical cannabis to treat concussions and other head injuries if research supports it as a valid treatment option. The league itself, however, has so far remained firm on its anti-cannabis stance and has continued to fine, suspend, or release players who fail drug tests or are caught in possession of cannabis.
But, as we continue to see for ourselves, change can happen gradually with enough time, persistence, and education. At this crucial moment for the NFL, Leafly has partnered with Americans for Safe Access to release a series of ads promoting medical cannabis as a treatment option for chronic pain, an ailment with which many professional football players are very familiar.
These ads, the first of which appeared yesterday in USA Today's NFL Special Edition, will run for 30 days and have a presence in markets for the Atlanta Falcons, Chicago Bears, Dallas Cowboys, Denver Broncos, Green Bay Packers, Miami Dolphins, New England Patriots, New York Giants, and Philadelphia Eagles. Those teams represent a variety of states that have either legalized cannabis recreationally, have established or are planning to launch some sort of medical cannabis program, or have no sort of legalization whatsoever. Consequently, we feel that these ads will reach not only a wide audience of football fans who may not be familiar with cannabis' therapeutic properties, but call attention to the pivotal crossroads the organization is currently facing and urge the league to support medical cannabis and allow its players the choice of legal, safe, and reasonable use of cannabis for valid medical reasons without repercussion.
Through our partnership with Americans for Safe Access, we hope to educate both the NFL and its fan base on this misunderstood plant and accelerate some must-needed change not just among the organization, but across the country as well.
For more information about this campaign, visit AmericansForSafeAccess.org/football.
This blog was originally posted by Leafly, the world's largest cannabis information resource. Rebecca Kelley is the Senior Content Marketing Manager for Leafly. She serves as the Editor-in-Chief for Leafly's News & Culture and Knowledge Center sections and also leads content responsibilities for Leafly's internal projects as well as its website and social media accounts.